# Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction

> **NCT05093959** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 86 (actual)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05093959
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-04
- **Primary completion:** 2025-12-18
- **Final completion:** 2026-04-16
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05093959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05093959, "Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05093959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*